# 18F-FAPI PET Imaging in Pancreatic Adenocarcinoma

> **NCT05884463** · NA · COMPLETED · sponsor: **Zhejiang University** · enrollment: 62 (actual)

## Conditions studied

- 18F-FAPI
- 18F-FDG
- Pancreas Adenocarcinoma
- Diagnosis
- Staging

## Interventions

- **DRUG:** 18F-FAPI
- **DRUG:** 18F-FDG

## Key facts

- **NCT ID:** NCT05884463
- **Lead sponsor:** Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-01
- **Primary completion:** 2023-02-28
- **Final completion:** 2023-02-28
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2023-06-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05884463

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05884463, "18F-FAPI PET Imaging in Pancreatic Adenocarcinoma". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05884463. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*